KMSTF
Price:
$3.21
Market Cap:
$125.73M
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was founded in 2008 and is based in Ness Ziona, Israel.
Industry
Biotechnology
IPO Date
2021-02-01
Stock Exchange
OTC
Ticker
KMSTF
According to Kadimastem Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -0.51. This represents a change of -58.29% compared to the average of -1.21 of the last 4 quarters.
The mean historical PE Ratio of Kadimastem Ltd over the last ten years is -6.45. The current -0.51 PE Ratio has changed 683.30% with respect to the historical average. Over the past ten years (40 quarters), KMSTF's PE Ratio was at its highest in in the September 2024 quarter at -0.72. The PE Ratio was at its lowest in in the September 2023 quarter at -26170.09.
Average
-6.45
Median
-3.42
Minimum
-21.51
Maximum
-1.08
Discovering the peaks and valleys of Kadimastem Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 307.02%
Maximum Annual PE Ratio = -1.08
Minimum Annual Increase = -90.44%
Minimum Annual PE Ratio = -21.51
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.06 | -90.44% |
| 2023 | -21.51 | 30.75% |
| 2022 | -16.46 | 307.02% |
| 2021 | -4.04 | 139.09% |
| 2020 | -1.69 | -39.57% |
| 2019 | -2.80 | 15.35% |
| 2018 | -2.43 | 123.80% |
| 2017 | -1.08 | -81.43% |
| 2016 | -5.84 | -11.92% |
| 2015 | -6.63 | 178.74% |
The current PE Ratio of Kadimastem Ltd (KMSTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.34
5-year avg
-9.15
10-year avg
-6.45
Kadimastem Ltd’s PE Ratio is greater than Organicell Regenerative Medicine, Inc. (-4.07), greater than OKYO Pharma Limited (-16.86), greater than OptiBiotix Health Plc (-41.38), greater than Antisense Therapeutics Limited (-0.51), less than Sorrento Therapeutics, Inc. (-0.00), less than PharmChem, Inc. (14.22), less than American Hemp Ventures, Inc. (0), greater than Noxopharm Limited (-5.56), greater than Renalytix Plc (-0.93), less than Yourgene Health Plc (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.07 | $19.97M | |
| -16.86 | $22.73M | |
| -41.38 | $20.06M | |
| -0.51 | $19.64M | |
| -0.00 | $16.54M | |
| 14.22 | $21.95M | |
| 0 | $16.47M | |
| -5.56 | $14.78M | |
| -0.93 | $22.55M | |
| 0 | $20.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kadimastem Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kadimastem Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Kadimastem Ltd's PE Ratio?
How is the PE Ratio calculated for Kadimastem Ltd (KMSTF)?
What is the highest PE Ratio for Kadimastem Ltd (KMSTF)?
What is the 3-year average PE Ratio for Kadimastem Ltd (KMSTF)?
What is the 5-year average PE Ratio for Kadimastem Ltd (KMSTF)?
How does the current PE Ratio for Kadimastem Ltd (KMSTF) compare to its historical average?